EGF and cancer: Some of these pathways are part of the EGF system signaling network, which becomes hyperactivated with various mechanisms (gain of function mutations, genomic amplification, chromosomal rearrangements and autocrine activation) and participates in cancer pathogenesis [37,38,39,40,41,42].